ArticleMedical oncology (Northwood, London, England)2022

Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations.

Mohammad Abohassan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.